Medications and Drugs
Brand Names: INOmax
Generic Name: nitric oxide (inhalation gas) (Pronunciation: NYE trik OX ide)
What is nitric oxide (INOmax)?
Nitric oxide is a gas that is inhaled. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs.
Nitric oxide is used together with a breathing machine (ventilator) to treat respiratory failure in premature babies.
Nitric oxide may also be used for other purposes not listed in this medication guide.
What are the possible side effects of nitric oxide (INOmax)?
Nitric oxide causes few side effects, but your baby may have noisy breathing, blood in the urine, or possibly a collapsed lung. There is also a possibility that the baby will have breathing difficulties after the nitric oxide treatment is stopped.
These problems may require further treatment by health care professionals. Your baby will remain under constant supervision during treatment with nitric oxide.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the most important information I should know about nitric oxide (INOmax)?
Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.
Nitric oxide is inhaled into the baby's lungs through the mouth or nose. Your baby may also be using a breathing tube connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).
Your baby will remain under constant supervision during treatment with nitric oxide.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Lung Disease/COPD Resources
- Controling of Treatment Side Effects
- Side Effects of New Treatments for CF: What You Need to Know
- 6 Health Tips During Lung Cancer Immunotherapy